Submitted by marti.velezis on 2021-09-30
Adverse Events as its own Data Class
We support the decoupling of Adverse Events (AE) from Allergies and Intolerances (A/I) as they are differentiated by context and temporal dimensions of clinical care. Also, the inclusion of FDA regulated medical products will ensure that we address the entire scope of products - including medical devices in order to address the differences from these two classes (i.e., AE and A/I). There is a case to include real world evidence and can only do so if these concepts are enabled through interoperability (i.e., USCDI).
Submitted by marti.velezis on 2021-10-01
Non-medication Allergies
Will this data element include allergies to materials (e.g., metals)? This should be included as well and if not already included in this scope we will need to submit a new submission.